A monop­oly is a mar­ket with a sin­gle seller. Monop­o­lies arise for sev­eral rea­sons. One is patents and copy­rights, which are granted to reward invest­ment in research and cre­ative work (med­i­cine patents are a com­mon exam­ple).

Another rea­son for a monop­oly is own­er­ship of key resources like coal mines. A monop­oly is also cre­ated when the gov­ern­ment grants a licence or fran­chise to a sin­gle com­pany (like a license for mak­ing defense equip­ment).

Main char­ac­ter­is­tics of a monop­oly mar­ket

  • There is a sin­gle seller with con­sid­er­able power over price.
  • The prod­uct has no close sub­sti­tute.
  • High bar­ri­ers to entry keep rivals out.

Exam­ples of monop­oly power

  • Microsoft has long held a dom­i­nant, near-monop­oly share of desk­top oper­at­ing sys­tems. Most com­puter users world­wide use Win­dows, and its copy­rights and patents make entry by a new com­pany dif­fi­cult.
  • When a phar­ma­ceu­ti­cal com­pany wins approval from the US Food and Drug Admin­is­tra­tion (FDA) for a new med­i­cine, it can receive a period of mar­ket exclu­siv­ity, for exam­ple seven years for an approved orphan drug. Dur­ing that period no other com­pany may sell the same med­i­cine, so research and devel­op­ment cre­ates a tem­po­rary monop­oly.

Key terms

Copy­right
Copy­right (or author's right) is a legal term used to describe the rights that cre­ators have over their lit­er­ary and artis­tic works.
Food and Drug Admin­is­tra­tion (FDA)
The US agency that pro­tects pub­lic health by mak­ing sure that med­i­cines, food, cos­met­ics and nutri­tional sup­ple­ments are safe and truth­fully labelled.
Intel­lec­tual Prop­erty Rights (IPR)
Intel­lec­tual Prop­erty Rights refers to the legal rights given to the inven­tor or cre­ator to pro­tect his inven­tion or cre­ation for a cer­tain time.
Fran­chise
An arrange­ment in which a com­pany sells another busi­ness the right to sell its prod­ucts or ser­vices in return for pay­ment.

Com­mon ques­tions

What is the dif­fer­ence between monop­o­lies and oli­gop­o­lies?

A monop­oly exists when one com­pany and its prod­uct dom­i­nate an entire indus­try, there is lit­tle to no com­pe­ti­tion, and con­sumers must pur­chase spe­cific goods or ser­vices from the one com­pany. An oli­gop­oly exists when a small num­ber of firms, as opposed to just one, dom­i­nates an entire indus­try. An oli­gop­oly allows for these firms to col­lude by restrict­ing sup­ply or fix­ing prices in order to achieve prof­its that are above nor­mal mar­ket returns.

Why are monop­o­lies cre­ated?

While gov­ern­ments usu­ally try to pre­vent monop­o­lies, in cer­tain sit­u­a­tions, they encour­age or even cre­ate monop­o­lies them­selves. In many cases, gov­ern­ment-cre­ated monop­o­lies are intended to result in economies of scale that ben­e­fit con­sumers by keep­ing costs down.

Util­ity com­pa­nies that pro­vide water, nat­ural gas, or elec­tric­ity are all exam­ples of enti­ties designed to ben­e­fit from economies of scale. Imag­ine, for exam­ple, the cost to con­sumers if 10 com­pet­ing water com­pa­nies each had to dig up the local streets to run pro­pri­etary water lines to every house in town. The same logic holds true for gas pipes and power grids.

In other cases, such as with the gov­ern­ment poli­cies that gov­ern copy­rights and patents, gov­ern­ments are seek­ing to encour­age inno­va­tion.

If inven­tors had no pro­tec­tion for their inven­tions, all of their time, effort, and money spent writ­ing books, record­ing songs, and con­duct­ing the research and devel­op­ment to cre­ate new drugs to com­bat dis­ease would be wasted if another com­pany could copy the idea and is able to cre­ate a com­pet­ing prod­uct at a lower cost.